Andere Kunden interessierten sich auch für
![Overview of Anemia and Thrombocytopenia in Cancer Patients]( "Overview of Anemia and Thrombocytopenia in Cancer Patients")
Overview of Anemia and Thrombocytopenia in Cancer Patients29,99 €![Twin births: frequency and management]( "Twin births: frequency and management")
Twin births: frequency and management29,99 €![Computerized System for the Detection of Stress through the Voice]( "Computerized System for the Detection of Stress through the Voice")
Computerized System for the Detection of Stress through the Voice26,99 €![Knee prosthesis failure in patients undergoing gonarthrosis surgery]( "Knee prosthesis failure in patients undergoing gonarthrosis surgery")
Knee prosthesis failure in patients undergoing gonarthrosis surgery26,99 €![Frequency of complications in newborns of diabetic mothers]( "Frequency of complications in newborns of diabetic mothers")
Frequency of complications in newborns of diabetic mothers26,99 €![Frequency of road traffic accidents in Lubumbashi]( "Frequency of road traffic accidents in Lubumbashi")
Frequency of road traffic accidents in Lubumbashi26,99 €![Acne treatment with a high-frequency device for men]( "Acne treatment with a high-frequency device for men")
Acne treatment with a high-frequency device for men26,99 €
Cancer is a general term for any disease in which certain cells in the human body divide in an uncontrolled manner (abnormal cell proliferation). The resulting new cells may form a malignant tumor (a neoplasm) or spread throughout the body. These cells all derive from the same clone, a cancer-initiating cell that has acquired certain characteristics enabling it to divide indefinitely. The aim of this study is to contribute to the improvement of care for children with cancer in the pediatric oncology unit of the University Clinics of Lubumbashi.We conducted a retrospective cross-sectional descriptive study in the Pediatric Oncology Unit at the University Clinics of Lubumbashi during the period from January 2012 to January 2022. We included all children treated with cancer drugs in the Pediatric Oncology Unit who had a platelet count of less than 100 G/L. Most patients had developed thrombocytopenia during the 3rd cycle of chemotherapy, with a frequency of 94.87%.